Frontiers in Therapy of Treatment-Resistant-Depression: A Future Role of Ketamine?
Many patients treated for major depression in mental health and primary care settings fail to respond to adequate trials of available evidence-based treatments. Antidepressants, psychotherapy, and brain stimulation therapies have had some success, but many individuals do not respond to these treatments. Ketamine, a dissociative general anesthetic agent, is emerging as an unexpected possible future treatment to help individuals who suffer from refractory major depression.